Logo
x

Search

Subscribe Now

OBI

OBI Entered into an Exclusive License Agreement with Odeon for OBI-999 and OBI-833 to Treat Cancer in China, Hong Kong and Macau

OBI Entered into an Exclusive License Agreement with Odeon for OBI-999 and OBI-833 to Treat Cancer in China, Hong Kong and Macau

  • February 22, 2022
Balanced Health: How Holistic Practices and Supplements Work Together for Wellness

    Balanced Health: How Holistic Practices and Supplements Work Together for Wellness

    • November 13, 2024
    PharmaShots Weekly Snapshots (October 07 – October 11, 2024)

      PharmaShots Weekly Snapshots (October 07 – October 11, 2024)

      • October 11, 2024
      Astellas Join Forces with AviadoBio for AVB-101 Gene Therapy Targeting Frontotemporal Dementia and Other Indications

        Astellas Join Forces with AviadoBio for AVB-101 Gene Therapy Targeting Frontotemporal Dementia and Other Indications

        • October 9, 2024
        Top 20 Generic Pharma Companies of 2024

          Top 20 Generic Pharma Companies of 2024

          • September 26, 2024
          Roche Reports Topline Data from P-III (REGENCY) Trial of Gazyva/Gazyvaro (Obinutuzumab) for Treating Lupus Nephritis

            Roche Reports Topline Data from P-III (REGENCY) Trial of Gazyva/Gazyvaro (Obinutuzumab) for Treating Lupus Nephritis

            • September 26, 2024
            Merck Animal Health Expands NOBIVAC NXT Platform to Include Vaccine for Feline Leukemia Virus

              Merck Animal Health Expands NOBIVAC NXT Platform to Include Vaccine for Feline Leukemia Virus

              • September 25, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.